The Demand for Nanoparticles in Drug Formulation is Rising

11.02.2022

Demand for nanoparticles in the biopharmaceutical industry is on the rise. Production of these tiny particles, which can protect and deliver medicines and vaccines where they need to go in the body, has been increasing since 1989.

Collaborating with an experienced partner, such as a CDMO, could prove to be invaluable in developing nano-based systems.

Read more about the benefits and challenges of nanoparticle production.

Emergent CDMO

Thought Leadership Nanoparticles

01.13.2022

A look inside our Center of Excellence for Development Services

From analytical development to drug substance and drug product process development and scale-up, we can help advance your...

03.19.2020

Vaxart AGREEMENT for Experimental Oral Vaccine Candidate for Coronavirus Disease

GAITHERSBURG, Md.,March 18, 2020(GLOBE NEWSWIRE) --Emergent BioSolutions Inc.(NYSE:EBS) announced today that it has entered...

09.01.2020

All Hands on Deck for Fill/Finish of Vaccines and Therapeutics

“Emergent has a long, successful history of working with the US government to develop, manufacture, and deliver safe and...